Respiratory Medicine
Volume 103, Issue 7 , Pages 951-962, July 2009

Endothelin receptor blockade in the management of pulmonary arterial hypertension: Selective and dual antagonism

  • Terence K. Trow

      Affiliations

    • Yale University School of Medicine, Division of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale Pulmonary Hypertension Center, 333 Cedar Street, LCI 105D, P.O. Box 208057, New Haven, CT 06520-8057, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 203 785 4196; fax: +1 203 785 3634.
    • ,
  • Darren B. Taichman

      Affiliations

    • Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA

Received 8 December 2008; accepted 19 February 2009. published online 23 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(09)00066-3

doi:10.1016/j.rmed.2009.02.016

Respiratory Medicine
Volume 103, Issue 7 , Pages 951-962, July 2009

Article Tools

* Image Usage & Resolution